Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality

Abstract excerpt

With the rapid global spread of SARS-CoV-2, we have become acutely aware of the inadequacies of our ability to respond to viral epidemics. Although disrupting the viral life cycle is critical for limiting viral spread and disease, it has proven challenging to develop targeted and selective therapeutics. Synthetic lethality offers a promising but largely unexploited strategy against infectious viral disease; as...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CRISPR and Genetic Engineering
• Share to SARS-CoV-2 and COVID-19 Research
• Share to Viral Infections and Outbreaks Research